Key result
Transaortic septal myectomy using mini-invasive surgical instruments significantly reduced maximum left ventricular outflow tract gradients from 94.4 mmHg to 11.6 mmHg.
Why the study?
Septal myectomy presents many technical challenges, limiting experienced centers globally, but applying mini-invasive surgical instruments may potentially reduce this difficulty.
Does transaortic septal myectomy using mini-invasive surgical instruments improve LVOT gradients and symptoms in patients with HOCM and drug-refractory symptoms?
Observational (n=168)
No
Does transaortic septal myectomy using mini-invasive surgical instruments improve LVOT gradients and symptoms in patients with HOCM and drug-refractory symptoms?
Transaortic septal myectomy using mini-invasive surgical instruments is a safe and effective approach that significantly reduces LVOT gradients and improves symptoms in patients with HOCM.
May ease myectomy technical demands in HOCM; hypothesis-generating and leaves open need for comparative outcome data.
BACKGROUND: Although septal myectomy is a standard strategy for managing patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms, so far, only a few experienced myectomy centers exist globally. Mainly, this can be explained by the many technical challenges presented by myectomy. From our clinical experience, applying the mini-invasive surgical instruments during myectomy potentially reduces the technical difficulty. This study reports the preliminary experience regarding transaortic septal myectomy using mini-invasive surgical instruments for managing patients with HOCM and drug-refractory symptoms; also, we evaluate the early results following myectomy. METHODS: Between March 2016 and March 2019, consecutive HOCM patients who underwent isolated transaortic septal myectomy using the mini-invasive surgical instruments were enrolled in this analysis. Intraoperative, in-hospital and follow-up results were analyzed. RESULTS: We included 168 eligible patients (83 males, mean 56.8 ± 12.3 years). The midventricular obstruction was recorded in 7 (4.2%) patients. All patients underwent transaortic septal myectomy with a mean aortic cross-clamping time of 36.0 ± 8.1 min. During myectomy, 9 (5.4%) patients received repeat aortic cross-clamping. Surgical mortality was 0.6%. Notably, 5 (3.0%) patients developed complete atrioventricular block, they needed permanent pacemaker implantation. The median follow-up time was 6 months; however, no follow-up deaths occurred with a significant improvement in New York Heart Association functional status. We reported a sharp decrease in the maximum gradients from the preoperative value (11.6 ± 7.4 mmHg vs. 94.4 ± 22.6 mmHg, p < 0.001). The median degree of mitral regurgitation fell to 1.0 (vs. 3.0 preoperatively, p < 0.001) with a significant reduction in the proportion of moderate or more regurgitation (1.2% vs. 57.7%, p < 0.001). CONCLUSIONS: Mini-invasive surgical instruments may be beneficial in reducing the technical challenges of transaortic septal myectomy procedure. Of note, transaortic septal myectomy using the mini-invasive surgical instruments may present with favorable results.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2021) conducted an observational in Hypertrophic obstructive cardiomyopathy (n=168). Transaortic septal myectomy using mini-invasive surgical instruments vs. Preoperative baseline was evaluated on Maximum LVOT gradient (mmHg) (p=<0.001). Transaortic septal myectomy using mini-invasive surgical instruments significantly reduced maximum left ventricular outflow tract gradients from 94.4 mmHg to 11.6 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: